{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:31:06Z","timestamp":1795098666524,"version":"4.10.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor immune microenvironment regulates the growth and metastasis of uveal melanoma (UM). This study aims to reveal the possible molecular mechanism of BRCA1-associated protein 1 (BAP1) mutations in affecting the tumor immune microenvironment in UM through mediating the nuclear factor-\u03baB (NF-\u03baB) signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>TCGA and cBioPortal databases jointly analyzed the genes with high mutation frequency in UM samples. Following survival analysis of UM patients, UM samples with BAP1 mutations were subjected to immune cell infiltration analysis. The signaling pathways associated with the mutated genes were screened by GSEA. Subsequently, the differential BAP1 expression was analyzed in the selected UM cell lines with wild type (WT) or mutant type (MUT) BAP1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Bioinformatics analysis identified 12 genes mutated in the UM samples, while only BAP1 mutations were related to the prognosis of UM patients. UM patients with BAP1 mutations had higher immune cell infiltration. BAP1 mutations inhibited the NF-\u03baB signaling pathway, suppressing the cytokine secretion and antigen presentation by macrophages. Rescue experiments confirmed that overexpressed NF-\u03baB could reverse the effect of BAP1 mutations on the immunosuppressive microenvironment, thus suppressing the malignant phenotypes of UM cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>BAP1 mutations may inhibit the NF-\u03baB signaling pathway, repressing the cytokine secretion and antigen presentation by macrophages, which induces the immunosuppressive microenvironment, enhances the malignant phenotypes of UM cells and ultimately promotes the growth and metastasis of UM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-023-00713-7","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T12:02:13Z","timestamp":1694692933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["BAP1 mutations inhibit the NF-\u03baB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma"],"prefix":"10.1186","volume":"29","author":[{"given":"Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-5248","authenticated-orcid":false,"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"issue":"4","key":"713_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10787-013-0170-z","volume":"21","author":"H Altaf","year":"2013","unstructured":"Altaf H, Revell PA. Evidence for active antigen presentation by monocyte\/macrophages in response to stimulation with particles: the expression of NFkappaB transcription factors and costimulatory molecules. Inflammopharmacology. 2013;21(4):279\u201390.","journal-title":"Inflammopharmacology"},{"issue":"8","key":"713_CR2","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.molonc.2014.06.004","volume":"8","author":"N Amirouchene-Angelozzi","year":"2014","unstructured":"Amirouchene-Angelozzi N, Nemati F, Gentien D, Nicolas A, Dumont A, Carita G, et al. Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target. Mol Oncol. 2014;8(8):1508\u201320.","journal-title":"Mol Oncol"},{"issue":"31","key":"713_CR3","doi-asserted-by":"publisher","first-page":"49623","DOI":"10.18632\/oncotarget.10418","volume":"7","author":"M Angi","year":"2016","unstructured":"Angi M, Kalirai H, Prendergast S, Simpson D, Hammond DE, Madigan MC, et al. In-depth proteomic profiling of the uveal melanoma secretome. Oncotarget. 2016;7(31):49623\u201335.","journal-title":"Oncotarget"},{"issue":"7","key":"713_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/tvst.9.7.39","volume":"9","author":"K Aughton","year":"2020","unstructured":"Aughton K, Shahidipour H, Djirackor L, Coupland SE, Kalirai H. Characterization of Uveal Melanoma Cell Lines and primary tumor samples in 3D culture. Transl Vis Sci Technol. 2020;9(7):39.","journal-title":"Transl Vis Sci Technol"},{"key":"713_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.exer.2019.02.012","volume":"181","author":"N Babchia","year":"2019","unstructured":"Babchia N, Landreville S, Clement B, Coulouarn C, Mouriaux F. The bidirectional crosstalk between metastatic uveal melanoma cells and hepatic stellate cells engenders an inflammatory microenvironment. Exp Eye Res. 2019;181:213\u201322.","journal-title":"Exp Eye Res"},{"issue":"8","key":"713_CR6","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/1541-7786.MCR-21-0657","volume":"20","author":"U Baqai","year":"2022","unstructured":"Baqai U, Purwin TJ, Bechtel N, Chua V, Han A, Hartsough EJ, et al. Multi-omics profiling shows BAP1 loss is Associated with upregulated cell adhesion molecules in Uveal Melanoma. Mol Cancer Res. 2022;20(8):1260\u201371.","journal-title":"Mol Cancer Res"},{"issue":"11","key":"713_CR7","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41416-022-01723-8","volume":"126","author":"AB Beasley","year":"2022","unstructured":"Beasley AB, Chen FK, Isaacs TW, Gray ES. Future perspectives of uveal melanoma blood based biomarkers. Br J Cancer. 2022;126(11):1511\u201328.","journal-title":"Br J Cancer"},{"issue":"15","key":"713_CR8","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","volume":"122","author":"C Chattopadhyay","year":"2016","unstructured":"Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, et al. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer. 2016;122(15):2299\u2013312.","journal-title":"Cancer"},{"issue":"10","key":"713_CR9","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/cells11101673","volume":"11","author":"S Diep","year":"2022","unstructured":"Diep S, Maddukuri M, Yamauchi S, Geshow G, Delk NA. Interleukin-1 and nuclear factor Kappa B Signaling promote breast Cancer Progression and Treatment Resistance. Cells. 2022;11(10):1673.","journal-title":"Cells"},{"issue":"1","key":"713_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cjp2.86","volume":"4","author":"N Farquhar","year":"2018","unstructured":"Farquhar N, Thornton S, Coupland SE, Coulson JM, Sacco JJ, Krishna Y, et al. Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma. J Pathol Clin Res. 2018;4(1):26\u201338.","journal-title":"J Pathol Clin Res"},{"issue":"4","key":"713_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/path.5384","volume":"250","author":"CR Figueiredo","year":"2020","unstructured":"Figueiredo CR, Kalirai H, Sacco JJ, Azevedo RA, Duckworth A, Slupsky JR, et al. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. J Pathol. 2020;250(4):420\u201339.","journal-title":"J Pathol"},{"issue":"5","key":"713_CR12","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.3390\/ijms22052669","volume":"22","author":"S Garcia-Mulero","year":"2021","unstructured":"Garcia-Mulero S, Alonso MH, Del Carpio LP, Sanz-Pamplona R, Piulats JM. Additive role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression. Int J Mol Sci. 2021;22(5):2669.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"713_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41388-020-01554-y","volume":"40","author":"A Han","year":"2021","unstructured":"Han A, Purwin TJ, Bechtel N, Liao C, Chua V, Seifert E, et al. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors. Oncogene. 2021;40(3):618\u201332.","journal-title":"Oncogene"},{"issue":"2","key":"713_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res. 2011;21(2):223\u201344.","journal-title":"Cell Res"},{"issue":"1","key":"713_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/CJP.CJP_75_19","volume":"63","author":"CY Huang","year":"2020","unstructured":"Huang CY, Yu LC. Distinct patterns of interleukin-12\/23 and tumor necrosis factor alpha synthesis by activated macrophages are modulated by glucose and colon cancer metabolites. Chin J Physiol. 2020;63(1):7\u201314.","journal-title":"Chin J Physiol"},{"issue":"1","key":"713_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, et al. Uveal melanoma. Nat Rev Dis Primers. 2020;6(1):24.","journal-title":"Nat Rev Dis Primers"},{"issue":"14","key":"713_CR18","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.3390\/cancers13143520","volume":"13","author":"GF Jang","year":"2021","unstructured":"Jang GF, Crabb JS, Hu B, Willard B, Kalirai H, Singh AD, et al. Proteomics of primary uveal melanoma: insights into metastasis and protein biomarkers. Cancers (Basel). 2021;13(14):3520.","journal-title":"Cancers (Basel)"},{"issue":"15","key":"713_CR19","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.3390\/cancers14153678","volume":"14","author":"CJ Kaler","year":"2022","unstructured":"Kaler CJ, Dollar JJ, Cruz AM, Kuznetsoff JN, Sanchez MI, Decatur CL, et al. BAP1 loss promotes suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas. Cancers (Basel). 2022;14(15):3678.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"713_CR20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/bjc.2014.417","volume":"111","author":"H Kalirai","year":"2014","unstructured":"Kalirai H, Dodson A, Faqir S, Damato BE, Coupland SE. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing. Br J Cancer. 2014;111(7):1373\u201380.","journal-title":"Br J Cancer"},{"key":"713_CR21","doi-asserted-by":"publisher","first-page":"785231","DOI":"10.3389\/fimmu.2022.785231","volume":"13","author":"EAT Koch","year":"2022","unstructured":"Koch EAT, Schaft N, Kummer M, Berking C, Schuler G, Hasumi K, et al. A one-armed phase I dose Escalation Trial Design: personalized vaccination with IKKbeta-Matured, RNA-Loaded dendritic cells for metastatic uveal melanoma. Front Immunol. 2022;13:785231.","journal-title":"Front Immunol"},{"issue":"10","key":"713_CR22","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.3390\/cancers12102832","volume":"12","author":"Y Krishna","year":"2020","unstructured":"Krishna Y, Acha-Sagredo A, Sabat-Pospiech D, Kipling N, Clarke K, Figueiredo CR, et al. Transcriptome profiling reveals New Insights into the Immune Microenvironment and Upregulation of Novel biomarkers in metastatic uveal melanoma. Cancers (Basel). 2020;12(10):2832.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"713_CR24","doi-asserted-by":"publisher","first-page":"e7952","DOI":"10.1590\/1414-431x20187952","volume":"52","author":"J Li","year":"2018","unstructured":"Li J, Fang R, Wang J, Deng L. NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt\/beta-catenin signaling pathway. Braz J Med Biol Res. 2018;52(1):e7952.","journal-title":"Braz J Med Biol Res"},{"key":"713_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.biochi.2023.04.013","volume":"212","author":"S Liau","year":"2023","unstructured":"Liau S, Wang JZ, Zagarella E, Paulus P, Dang N, Rawling T, et al. An update on inflammation in uveal melanoma. Biochimie. 2023;212:114\u201322.","journal-title":"Biochimie"},{"issue":"2","key":"713_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-21-1171","volume":"82","author":"W Liu","year":"2022","unstructured":"Liu W, Stachura P, Xu HC, Varaljai R, Shinde P, Ganesh NU, et al. BAFF attenuates immunosuppressive Monocytes in the Melanoma Tumor Microenvironment. Cancer Res. 2022;82(2):264\u201377.","journal-title":"Cancer Res"},{"key":"713_CR26","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.ctrv.2020.102091","volume":"90","author":"BH Louie","year":"2020","unstructured":"Louie BH, Kurzrock R. BAP1: not just a BRCA1-associated protein. Cancer Treat Rev. 2020;90:102091.","journal-title":"Cancer Treat Rev"},{"key":"713_CR27","doi-asserted-by":"publisher","first-page":"754645","DOI":"10.3389\/fimmu.2022.754645","volume":"13","author":"Z Meng","year":"2022","unstructured":"Meng Z, Chen Y, Wu W, Yan B, Zhang L, Chen H, et al. PRRX1 is a Novel Prognostic Biomarker and facilitates Tumor Progression through epithelial-mesenchymal transition in Uveal Melanoma. Front Immunol. 2022;13:754645.","journal-title":"Front Immunol"},{"key":"713_CR28","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3389\/fimmu.2020.01276","volume":"11","author":"EM Muntjewerff","year":"2020","unstructured":"Muntjewerff EM, Meesters LD, van den Bogaart G. Antigen Cross-Presentation by Macrophages. Front Immunol. 2020;11:1276.","journal-title":"Front Immunol"},{"issue":"2","key":"713_CR29","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.18632\/aging.102693","volume":"12","author":"H Pan","year":"2020","unstructured":"Pan H, Lu L, Cui J, Yang Y, Wang Z, Fan X. Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis. Aging. 2020;12(2):1446\u201364.","journal-title":"Aging"},{"issue":"8","key":"713_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/cancers11081043","volume":"11","author":"L Piquet","year":"2019","unstructured":"Piquet L, Dewit L, Schoonjans N, Millet M, Berube J, Gerges PRA, et al. Synergic interactions between hepatic stellate cells and uveal melanoma in metastatic growth. Cancers (Basel). 2019;11(8):1043.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"713_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","volume":"53","author":"J Read","year":"2016","unstructured":"Read J, Wadt KA, Hayward NK. Melanoma genetics. J Med Genet. 2016;53(1):1\u201314.","journal-title":"J Med Genet"},{"issue":"1","key":"713_CR32","first-page":"1","volume":"77","author":"S Rusnak","year":"2020","unstructured":"Rusnak S, Hecova L, Kasl Z, Sobotova M, Hauer L. Therapy of uveal melanoma a review. Cesk Slov Oftalmol. 2020;77(1):1\u201313.","journal-title":"Cesk Slov Oftalmol"},{"issue":"7","key":"713_CR34","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41588-019-0440-9","volume":"51","author":"AH Shain","year":"2019","unstructured":"Shain AH, Bagger MM, Yu R, Chang D, Liu S, Vemula S, et al. The genetic evolution of metastatic uveal melanoma. Nat Genet. 2019;51(7):1123\u201330.","journal-title":"Nat Genet"},{"issue":"12","key":"713_CR35","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1007\/s12094-018-1895-3","volume":"20","author":"MK Singh","year":"2018","unstructured":"Singh MK, Pushker N, Meel R, Chodsol K, Sen S, Bakhshi S, et al. Does NEMO\/IKKgamma protein have a role in determining prognostic significance in uveal melanoma? Clin Transl Oncol. 2018;20(12):1592\u2013603.","journal-title":"Clin Transl Oncol"},{"key":"713_CR36","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.preteyeres.2019.100800","volume":"75","author":"KN Smit","year":"2020","unstructured":"Smit KN, Jager MJ, de Klein A, Kili E. Uveal melanoma: towards a molecular understanding. Prog Retin Eye Res. 2020;75:100800.","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"713_CR33","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cancers11081102","volume":"11","author":"Z Souri","year":"2019","unstructured":"Souri Z, Wierenga APA, van Weeghel C, van der Velden PA, Kroes WGM, Luyten GPM, et al. Loss of BAP1 is Associated with Upregulation of the NFkB Pathway and increased HLA class I expression in Uveal Melanoma. Cancers (Basel). 2019;11(8):1102.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"713_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s11914-022-00729-8","volume":"20","author":"HW Tseng","year":"2022","unstructured":"Tseng HW, Samuel SG, Schroder K, Levesque JP, Alexander KA. Inflammasomes and the IL-1 family in bone homeostasis and disease. Curr Osteoporos Rep. 2022;20(3):170\u201385.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"713_CR39","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1038\/s41598-020-59095-z","volume":"10","author":"MN Viana","year":"2020","unstructured":"Viana MN, Leiguez E, Gutierrez JM, Rucavado A, Markus RP, Marcola M, et al. A representative metalloprotease induces PGE2 synthesis in fibroblast-like synoviocytes via the NF-kappaB\/COX-2 pathway with amplification by IL-1beta and the EP4 receptor. Sci Rep. 2020;10(1):3269.","journal-title":"Sci Rep"},{"issue":"8","key":"713_CR40","doi-asserted-by":"publisher","first-page":"e2025840118","DOI":"10.1073\/pnas.2025840118","volume":"118","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Bastian IN, Long MD, Dow M, Li W, Liu T, et al. Activation of NF-kappaB and p300\/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. Proc Natl Acad Sci U S A. 2021;118(8):e2025840118.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00713-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:49:58Z","timestamp":1700516998000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00713-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00713-7","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"27 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve human or animal material or data. Ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}